Yu v. Dr Pepper Snapple Group, Inc.

CourtDistrict Court, N.D. California
DecidedOctober 6, 2020
Docket5:18-cv-06664
StatusUnknown

This text of Yu v. Dr Pepper Snapple Group, Inc. (Yu v. Dr Pepper Snapple Group, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Yu v. Dr Pepper Snapple Group, Inc., (N.D. Cal. 2020).

Opinion

1 2 3 UNITED STATES DISTRICT COURT 4 NORTHERN DISTRICT OF CALIFORNIA 5 SAN JOSE DIVISION 6 7 HAWYUAN YU, Case No. 18-cv-06664-BLF

8 Plaintiff, ORDER GRANTING DEFENDANT'S 9 v. MOTION TO DISMISS WITHOUT LEAVE TO AMEND 10 DR PEPPER SNAPPLE GROUP, INC., et al., [Re: ECF 47] 11 Defendants. 12 13 For the second time, Plaintiff Hawyuan Yu brings a complaint against Defendants Dr 14 Pepper Snapple Group, Inc. (“Dr. Pepper”) and Mott’s, LLP (collectively, “Defendants”) on 15 behalf of a putative class. Defendants have filed another motion to dismiss the complaint, 16 advocating for outright dismissal with prejudice or, alternatively, a stay. See Mot., ECF 47. 17 Plaintiff’s main allegation remains the same: Defendants mislead consumers by selling 18 apple juice and applesauce products with the representation “Natural” and/or “All Natural 19 Ingredients” that nonetheless contain trace amounts of a pesticide. The same five causes of action 20 are back again as well. The only thing that has changed is that Plaintiff has added two generic 21 surveys to the allegations the Court already held insufficient once. Since the Ninth Circuit has 22 recently made clear that this addition alone will not do, the Court GRANTS Defendant’s motion to 23 dismiss. Because Plaintiff has already received a second chance at stating a claim upon which 24 relief could be granted, the Court finds further amended futile and dismisses the complaint 25 WITHOUT leave to amend. 26 27 I. BACKGROUND 1 California. Am. Compl. (“FAC”) ¶ 27. Defendant Dr. Pepper is incorporated in Delaware with its 2 principal place of business in Plano, Texas. Id. ¶ 31. Defendant Mott’s is a subsidiary of Dr. 3 Pepper and is incorporated in Delaware with its principal place of business in Rye Brook, New 4 York. Id. ¶ 32. Defendants sell several applesauce and apple juice products (“the Products”), 5 including Mott’s Natural Unsweetened Applesauce, Mott’s Healthy Harvest Applesauce, Mott’s 6 Natural 100% Juice Apple Juice, and other varieties of Mott’s brand applesauce and apple juice 7 products that include the representation “Natural” and/or “All Natural Ingredients” on the product 8 package or label. See id. ¶¶ 1, 5, 7. Defendants sell these products nationwide. Id. ¶¶ 10, 33. 9 Plaintiff purchased Mott’s Natural Applesauce and Natural Apple Juice on multiple 10 occasions from a Costco Warehouse in Sunnyvale, California, and a Safeway Store in San Jose, 11 California. FAC ¶ 28. Plaintiff alleges that in deciding to make these purchases, Plaintiff saw, 12 relied upon, and reasonably believed Defendants’ representations that the products were “Natural” 13 and made of “All Natural Ingredients.” Id. ¶ 29. Plaintiff further alleges that he was “willing to 14 pay more for Defendants’ Products because he expected the Products to be free of insecticides and 15 other unnatural chemicals.” Id. ¶ 30. 16 According to the complaint, though, Defendants’ applesauce and apple juice products 17 contain acetamiprid, a “synthetic and unnatural chemical.” See FAC ¶¶ 10, 11. Acetamiprid is a 18 synthetic insecticide used in treating and harvesting crops, including fruits and vegetables. Id. ¶¶ 19 12, 13. Acetamiprid may be hazardous to human development and to other animals, including the 20 honeybee. Id. ¶ 12. Acetamiprid is “legal” in connection with food products, insofar as its use is 21 not precluded and certain amounts of residuals are permitted to remain on fruits and vegetables. 22 Id. ¶ 13. Plaintiff’s primary theory of liability is not that the acetamiprid present in Defendants’ 23 products exceeds the legal limit, but instead that “[r]easonable consumers who see Defendants’ 24 representations that the Products contain ‘All Natural Ingredients’ or are ‘natural’ expect the 25 Products to meet a higher standard than competing products not advertised as ‘natural,’ and do not 26 expect the Products to contain traces of a synthetic insecticide.” Id. ¶¶ 14, 15. 27 According to Plaintiff, Defendants’ representations that the Products are made of “All 1 believes that Products that are “natural” do not contain a synthetic and unnatural pesticide, even in 2 residual amounts. FAC ¶ 37. Plaintiff cites a study conducted in January 2019 (“2019 Study”) that 3 stated that 68.1 percent of consumers would consider food produced from crops sprayed with 4 synthetic pesticides not natural. FAC ¶ 38; Ex. C, the 2019 Study at 29, ECF 48-3. Plaintiff also 5 cites a 2015 Consumer Reports phone survey (“2015 Consumer Reports Survey”) that found that 6 63 percent of respondents think that the natural label on packaged and processed foods means that 7 “no toxic pesticides were used.” FAC ¶ 39; Ex. B, 2015 Consumer Reports Survey at 6, ECF 48-3. 8 The 2015 Consumer Reports Survey also states that “Consumers were asked about their 9 perception of the natural and organic labels. The organic food label is meaningful, is backed by 10 federal regulations, and verified by third-party inspections; the natural label, however, is 11 essentially meaningless (little regulation/verification).” 2015 Consumer Reports Survey at 4. 12 Plaintiff proposes a nationwide class of consumers who purchased Defendants’ Products- 13 in-question, as well as a California subclass. See FAC ¶¶ 72–87. Plaintiff asserts five causes of 14 action: (1) Unfair and Deceptive Acts and Practices under the California Legal Remedies Act 15 (“CLRA”), Cal. Civ. Code §§ 1750–1785 (on behalf of the California subclass); (2) Violation of 16 California’s False Advertising Law (“FAL”), Cal. Bus. & Prof. Code §§ 17500 et seq. (on behalf 17 of the California subclass); (3) Violation of California’s Unfair Competition Law (“UCL”), Cal. 18 Bus. & Prof. Code §§ 17200 et seq. (on behalf of the California subclass); (4) Breach of Express 19 Warranty (on behalf of the nationwide class); and (5) Unjust enrichment (on behalf of the 20 nationwide class). See id. ¶¶ 88-128. 21 The Court previously granted Defendants’ motion to dismiss the original complaint on all 22 five claims with leave to amend. See Order (“Dismissal Order”), ECF 40. The Court also stayed 23 the case through the end of February 2020 under the primary jurisdiction doctrine because of 24 ongoing FDA regulatory proceedings to define the term ‘natural’ for food labeling. Dismissal 25 Order 8–10. That process has yet to conclude. 26 II. LEGAL STANDARD 27 A. Rule 12(b)(6) 1 accepted as true, to ‘state a claim to relief that is plausible on its face.’” Ashcroft v. Iqbal, 556 U.S. 2 662, 678 (2009) (quoting Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 570 (2007)). When 3 considering such a motion, the Court “accept[s] factual allegations in the complaint as true and 4 construe[s] the pleadings in the light most favorable to the nonmoving party.” Manzarek v. St. 5 Paul Fire & Marine Ins. Co., 519 F.3d 1025, 1031 (9th Cir. 2008). However, the Court need not 6 “accept as true allegations that contradict matters properly subject to judicial notice” or 7 “allegations that are merely conclusory, unwarranted deductions of fact, or unreasonable 8 inferences.” In re Gilead Scis. Sec. Litig., 536 F.3d 1049, 1055 (9th Cir. 2008) (internal quotation 9 marks and citations omitted). “Threadbare recitals of the elements of a cause of action, supported 10 by mere conclusory statements, do not suffice.” Iqbal, 556 U.S. at 678 (citing Twombly, 550 U.S. 11 at 555). 12 B. Rule 12(b)(1) 13 “Federal courts are courts of limited jurisdiction.” Kokkonen v. Guardian Life Ins. Co. of 14 Am., 511 U.S. 375, 377 (1994).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
Kokkonen v. Guardian Life Insurance Co. of America
511 U.S. 375 (Supreme Court, 1994)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Watters v. Wachovia Bank, N. A.
550 U.S. 1 (Supreme Court, 2007)
Bartlett v. Strickland
556 U.S. 1 (Supreme Court, 2009)
Lee v. City Of Los Angeles
250 F.3d 668 (Ninth Circuit, 2001)
Galbraith v. County Of Santa Clara
307 F.3d 1119 (Ninth Circuit, 2002)
United States v. Jasper Black
482 F.3d 1035 (Ninth Circuit, 2007)
Manzarek v. St. Paul Fire & Marine Insurance
519 F.3d 1025 (Ninth Circuit, 2008)
Williams v. Gerber Products Co.
552 F.3d 934 (Ninth Circuit, 2008)
Intri-Plex Technologies, Inc. v. Crest Group, Inc.
499 F.3d 1048 (Ninth Circuit, 2007)
In Re Gilead Sciences Securities Litigation
536 F.3d 1049 (Ninth Circuit, 2008)
Lavie v. Procter & Gamble Co.
129 Cal. Rptr. 2d 486 (California Court of Appeal, 2003)
Karim Khoja v. Orexigen Therapeutics, Inc.
899 F.3d 988 (Ninth Circuit, 2018)
Shana Becerra v. Dr pepper/seven Up, Inc.
945 F.3d 1225 (Ninth Circuit, 2019)
Axon v. Citrus World, Inc.
354 F. Supp. 3d 170 (E.D. New York, 2018)
Parks v. Ainsworth Pet Nutrition, LLC
377 F. Supp. 3d 241 (S.D. Illinois, 2019)
Safe Air for Everyone v. Meyer
373 F.3d 1035 (Ninth Circuit, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
Yu v. Dr Pepper Snapple Group, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/yu-v-dr-pepper-snapple-group-inc-cand-2020.